Stock Movers: FedEx, Unilever, Planet Labs (Podcast)

FedEx raised its full-year profit forecast, sending its shares up the most in nearly a year and indicating progress on its delivery-network restructuring. Unilever is in talks to sell its food business to McCormick & Co., a potential major divestiture for the owner of Hellmann’s. Planet Labs beat fourth-quarter revenue expectations and topped its 2027 revenue forecast, supporting its recent stock gains.

Analysis

FedEx’s stock move looks less like a pure demand story and more like a proof point for structural margin recovery from network reconfiguration; the economic lever is utilization uplift + asset rationalization, which can drive 200–400bps of operating margin improvement over 12–18 months if executed cleanly. The key second-order beneficiary is large shippers with stable volumes (consumer staples, pharma) that can re-negotiate contracts as capacity tightens, while regional LTL and third‑party carriers will face margin pressure as excess volumes flow back into scaled networks. Execution risk is binary: a single major operational hiccup or strike during a peak window could wipe out the implied forward multiple expansion in weeks, not months.

Unilever’s potential divestiture is a corporate-structure catalyst that should repurpose capital toward higher-margin personal care/household categories and M&A flexibility; a credible break-up can unlock a 10–20% multiple expansion within 6–12 months if management commits to buybacks or bolt-on buys with better ROIC. Conversely, McCormick taking on commoditized brands increases exposure to grocery trade rationalization and SKU pruning, creating 1–3 year carve‑out integration and working capital drag. Regulators and retailer negotiation leverage are medium-term reversal points — antitrust scrutiny or hard contract renegotiations with Walmart/Tesco could materially compress near-term accretion assumptions.

Planet Labs’ metric beat is an early sign of scalable recurring data revenue, but margin realization requires customer lifetime value > 3x CAC and steady satellite uptime — capital intensity and launch cadence are the choke points over the next 12–36 months. AI demand for geospatial training data amplifies TAM and could accelerate enterprise ARR conversion, but competitive pressure from Maxar and synthetic alternatives caps pricing power and delays breakeven. Treat the stock as a growth/operational-risk play: upside if subscription economics normalize, downside if launches or data quality issues force additional dilutive raises.

Key Decisions for Investors

• Long FDX (12-month horizon): buy FDX calls ~15–25% OTM with position size equal to 1–2% of fund NAV or construct a 12-month call spread to cap premium. R/R: skewed to the upside if network saves 200–400bps in OpEx; downside limited to premium paid but execution/strike risk can erase time premium quickly — hedge with a short allocation to cyclical freight names.
• Pair trade ULVR vs MKC (6–18 months): go long ULVR equity or 6–12 month calls (expect ~+15–25% if deal completes and multiple rerates) and short MKC equity (expect downside ~-10–15% on integration/leverage risk). R/R: asymmetric—ULVR re-rate on simplification; MKC bears one-time goodwill and margins pressure.
• Long PL (9–18 months, smaller size): buy 9–12 month calls or outright equity small position (0.5–1% NAV) to capture SaaS-like ARR re-rating if churn falls and launches remain on schedule. R/R: high upside if ARR growth accelerates and gross margins improve; high dilution/operational failure risk — size accordingly and set stop at 25–30% drawdown.
• Tactical pair to hedge execution risk (3–6 months): long FDX / short XPO (or another regional/asset-light logistics name) to express network consolidation wins while hedging macro-volume declines. R/R: captures relative operational win; downside if broad volumes collapse and both names suffer.